ticlopidine has been researched along with Short Bowel Syndrome in 2 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
Short Bowel Syndrome: A malabsorption syndrome resulting from extensive operative resection of the SMALL INTESTINE, the absorptive region of the GASTROINTESTINAL TRACT.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hadley, G | 1 |
Harrison, P | 1 |
Adlam, D | 1 |
Choudhury, RP | 1 |
Droppa, M | 1 |
Karathanos, A | 1 |
Gawaz, M | 1 |
Geisler, T | 1 |
2 other studies available for ticlopidine and Short Bowel Syndrome
Article | Year |
---|---|
Short bowel syndrome and clopidogrel non-responsiveness: a new indication for platelet aggregometry?
Topics: Adenosine; Aged; Aspirin; Clopidogrel; Drug Resistance; Drug Therapy, Combination; Female; Humans; P | 2014 |
Individualised dual antiplatelet therapy in a patient with short bowel syndrome after acute myocardial infarction with coronary artery stenting.
Topics: Abdominal Pain; Anterior Wall Myocardial Infarction; Aspirin; Clopidogrel; Cytochrome P-450 CYP2C19; | 2015 |